DERMIRA INC's ticker is DERM and the CUSIP is 24983L104. A total of 132 filers reported holding DERMIRA INC in Q3 2019. The put-call ratio across all filers is 1.28 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $173,000 | +183.6% | 11,440 | +20.2% | 0.00% | – |
| Q3 2019 | $61,000 | -33.0% | 9,520 | 0.0% | 0.00% | – |
| Q2 2019 | $91,000 | -8.1% | 9,520 | +30.9% | 0.00% | – |
| Q1 2019 | $99,000 | +135.7% | 7,273 | +24.7% | 0.00% | – |
| Q4 2018 | $42,000 | -33.3% | 5,834 | 0.0% | 0.00% | – |
| Q3 2018 | $63,000 | +16.7% | 5,834 | 0.0% | 0.00% | – |
| Q2 2018 | $54,000 | -3.6% | 5,834 | -17.8% | 0.00% | – |
| Q1 2018 | $56,000 | -79.0% | 7,100 | -25.9% | 0.00% | – |
| Q4 2017 | $267,000 | -3.3% | 9,588 | -6.4% | 0.00% | – |
| Q3 2017 | $276,000 | -1.8% | 10,245 | +6.0% | 0.00% | – |
| Q2 2017 | $281,000 | +19.1% | 9,664 | +40.9% | 0.00% | – |
| Q1 2017 | $236,000 | +32.6% | 6,861 | +16.3% | 0.00% | – |
| Q4 2016 | $178,000 | +119.8% | 5,898 | +134.1% | 0.00% | – |
| Q3 2016 | $81,000 | +1.2% | 2,519 | -7.6% | 0.00% | – |
| Q2 2016 | $80,000 | +45.5% | 2,726 | 0.0% | 0.00% | – |
| Q1 2016 | $55,000 | -41.5% | 2,726 | 0.0% | 0.00% | – |
| Q4 2015 | $94,000 | – | 2,726 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ORACLE INVESTMENT MANAGEMENT INC | 1,760,072 | $16,826,000 | 3.62% |
| NEA Management Company, LLC | 3,506,649 | $33,524,000 | 2.35% |
| GREAT POINT PARTNERS LLC | 1,552,900 | $14,846,000,000 | 1.65% |
| APIS CAPITAL ADVISORS, LLC | 100,000 | $956,000 | 1.43% |
| NEXTHERA CAPITAL LP | 138,102 | $1,320,000 | 1.10% |
| Eversept Partners, LP | 399,874 | $3,822,795 | 1.07% |
| Jeneq Management LP | 96,570 | $923,000 | 0.82% |
| Trellus Management Company, LLC | 60,000 | $574,000 | 0.78% |
| PFM Health Sciences, LP | 4,044,542 | $38,666,000 | 0.73% |
| Birchview Capital, LP | 120,000 | $1,147,000 | 0.70% |